Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.73 Analyst target: $12.00 Upside: 1543.61%
PainReform Ltd., a pharmaceutical company specializing in clinical stages, is dedicated to the development of therapies that provide an extended period of post-surgical pain relief in Israel. The company is headquartered in Tel Aviv, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.